|
gptkbp:instance_of
|
gptkb:medical_devices
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:available_in
|
various sizes
|
|
gptkbp:clinical_trial
|
GORE® EXCLUDER® Clinical Study
|
|
gptkbp:clinical_use
|
used in endovascular aneurysm repair (EVAR)
|
|
gptkbp:complications
|
endoleak
|
|
gptkbp:contraindication
|
severe vascular disease
uncontrolled infection
anatomical limitations
|
|
gptkbp:customer_satisfaction
|
generally high
|
|
gptkbp:designed_for
|
treatment of abdominal aortic aneurysms
|
|
gptkbp:events
|
regular imaging required
|
|
gptkbp:features
|
dual-layer design
|
|
gptkbp:first_introduced
|
gptkb:2002
|
|
gptkbp:follow_up_schedule
|
annual follow-up recommended
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
GORE® EXCLUDER® AAA Endoprosthesis
|
|
gptkbp:innovation
|
improved delivery system
|
|
gptkbp:long_term_outcomes
|
monitored for durability
|
|
gptkbp:manufacturer
|
gptkb:W._L._Gore_&_Associates
|
|
gptkbp:marketed_as
|
gptkb:GORE®_EXCLUDER®_AAA_Endoprosthesis
|
|
gptkbp:material
|
e PTFE
|
|
gptkbp:patient_education
|
informed consent required
|
|
gptkbp:patient_population
|
adults
|
|
gptkbp:postoperative_care
|
monitor for complications
|
|
gptkbp:provides_guidance_on
|
follow vascular surgery guidelines
|
|
gptkbp:risk_factor
|
gptkb:disease
gptkb:migration
hypertension
smoking
family history of aneurysms
thrombus formation
|
|
gptkbp:specialties
|
percutaneous access
|
|
gptkbp:success_rate
|
high success rate
|
|
gptkbp:treatment
|
reduces risk of aneurysm rupture
|
|
gptkbp:type
|
endovascular stent graft
|
|
gptkbp:used_in
|
minimally invasive surgery
|
|
gptkbp:bfsParent
|
gptkb:Gore_Endovascular
|
|
gptkbp:bfsLayer
|
7
|